Jaime Ibarrola

1.1k total citations
30 papers, 772 citations indexed

About

Jaime Ibarrola is a scholar working on Surgery, Immunology and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, Jaime Ibarrola has authored 30 papers receiving a total of 772 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Surgery, 12 papers in Immunology and 11 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in Jaime Ibarrola's work include Hormonal Regulation and Hypertension (11 papers), Cardiovascular, Neuropeptides, and Oxidative Stress Research (10 papers) and Galectins and Cancer Biology (10 papers). Jaime Ibarrola is often cited by papers focused on Hormonal Regulation and Hypertension (11 papers), Cardiovascular, Neuropeptides, and Oxidative Stress Research (10 papers) and Galectins and Cancer Biology (10 papers). Jaime Ibarrola collaborates with scholars based in Spain, France and United States. Jaime Ibarrola's co-authors include Natalia López‐Andrés, Amaya Fernández‐Celis, Ernesto Martínez‐Martínez, Frédéric Jaisser, Victoria Cachofeiro, Patrick Rossignol, Vanessa Arrieta, Patrick Rossignol, Rafael Sádaba and Virginia Álvarez and has published in prestigious journals such as PLoS ONE, Circulation Research and Diabetes.

In The Last Decade

Jaime Ibarrola

29 papers receiving 758 citations

Peers

Jaime Ibarrola
Jaime Ibarrola
Citations per year, relative to Jaime Ibarrola Jaime Ibarrola (= 1×) peers Elisabeth Schieffer

Countries citing papers authored by Jaime Ibarrola

Since Specialization
Citations

This map shows the geographic impact of Jaime Ibarrola's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jaime Ibarrola with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jaime Ibarrola more than expected).

Fields of papers citing papers by Jaime Ibarrola

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jaime Ibarrola. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jaime Ibarrola. The network helps show where Jaime Ibarrola may publish in the future.

Co-authorship network of co-authors of Jaime Ibarrola

This figure shows the co-authorship network connecting the top 25 collaborators of Jaime Ibarrola. A scholar is included among the top collaborators of Jaime Ibarrola based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jaime Ibarrola. Jaime Ibarrola is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ibarrola, Jaime, et al.. (2024). Inhibition of the histone methyltransferase EZH2 induces vascular stiffness. Clinical Science. 138(5). 251–268. 9 indexed citations
2.
Camarda, Nicholas D., et al.. (2024). Mineralocorticoid Receptor in Endothelial Cells Contributes to Vascular Endothelial Growth Factor Receptor Inhibitor-Induced Vascular and Kidney Damage. American Journal of Hypertension. 38(2). 104–110. 1 indexed citations
3.
Ibarrola, Jaime & Iris Z. Jaffe. (2023). The Mineralocorticoid Receptor in the Vasculature: Friend or Foe?. Annual Review of Physiology. 86(1). 49–70. 9 indexed citations
4.
Ibarrola, Jaime, Seung Kyum Kim, Qing Lu, et al.. (2022). Smooth muscle mineralocorticoid receptor as an epigenetic regulator of vascular ageing. Cardiovascular Research. 118(17). 3386–3400. 16 indexed citations
5.
6.
García-Peña, Amaia, Jaime Ibarrola, Adela Navarro, et al.. (2021). Activation of the Interleukin-33/ST2 Pathway Exerts Deleterious Effects in Myxomatous Mitral Valve Disease. International Journal of Molecular Sciences. 22(5). 2310–2310. 6 indexed citations
7.
Ibarrola, Jaime, Amaia García-Peña, Lara Matilla, et al.. (2020). A New Role for the Aldosterone/Mineralocorticoid Receptor Pathway in the Development of Mitral Valve Prolapse. Circulation Research. 127(3). e80–e93. 16 indexed citations
8.
Ibarrola, Jaime, Amaya Fernández‐Celis, Morten Schou, et al.. (2020). The Mineralocorticoid Receptor Antagonist Eplerenone Suppresses Interstitial Fibrosis in Subcutaneous Adipose Tissue in Patients With Type 2 Diabetes. Diabetes. 70(1). 196–203. 5 indexed citations
9.
Ibarrola, Jaime, Amaia García-Peña, Lara Matilla, et al.. (2020). Beneficial Effects of Mineralocorticoid Receptor Antagonism on Myocardial Fibrosis in an Experimental Model of the Myxomatous Degeneration of the Mitral Valve. International Journal of Molecular Sciences. 21(15). 5372–5372. 13 indexed citations
10.
Ibarrola, Jaime, Lara Matilla, Ernesto Martínez‐Martínez, et al.. (2019). Myocardial Injury After Ischemia/Reperfusion Is Attenuated By Pharmacological Galectin-3 Inhibition. Scientific Reports. 9(1). 9607–9607. 43 indexed citations
11.
Leite, Sara, Rui Cerqueira, Jaime Ibarrola, et al.. (2019). Arterial Remodeling and Dysfunction in the ZSF1 Rat Model of Heart Failure With Preserved Ejection Fraction. Circulation Heart Failure. 12(7). e005596–e005596. 21 indexed citations
12.
Ibarrola, Jaime, Rafael Sádaba, Amaia García-Peña, et al.. (2018). A role for fumarate hydratase in mediating oxidative effects of galectin-3 in human cardiac fibroblasts. International Journal of Cardiology. 258. 217–223. 17 indexed citations
13.
Ibarrola, Jaime, Rafael Sádaba, Ernesto Martínez‐Martínez, et al.. (2018). Aldosterone Impairs Mitochondrial Function in Human Cardiac Fibroblasts via A-Kinase Anchor Protein 12. Scientific Reports. 8(1). 6801–6801. 24 indexed citations
14.
Martínez‐Martínez, Ernesto, Jaime Ibarrola, Amaya Fernández‐Celis, et al.. (2017). Differential Proteomics Identifies Reticulocalbin-3 as a Novel Negative Mediator of Collagen Production in Human Cardiac Fibroblasts. Scientific Reports. 7(1). 12192–12192. 27 indexed citations
15.
Martínez‐Martínez, Ernesto, Jaime Ibarrola, Amaya Fernández‐Celis, et al.. (2017). Galectin-3 pharmacological inhibition attenuates early renal damage in spontaneously hypertensive rats. Journal of Hypertension. 36(2). 368–376. 41 indexed citations
16.
Martínez‐Martínez, Ernesto, Jaime Ibarrola, Mercedes Lachén‐Montes, et al.. (2017). Differential proteomics reveals S100-A11 as a key factor in aldosterone-induced collagen expression in human cardiac fibroblasts. Journal of Proteomics. 166. 93–100. 9 indexed citations
17.
Buonafine, Mathieu, Ernesto Martínez‐Martínez, Cristián A. Amador, et al.. (2017). Neutrophil Gelatinase-Associated Lipocalin from immune cells is mandatory for aldosterone-induced cardiac remodeling and inflammation. Journal of Molecular and Cellular Cardiology. 115. 32–38. 48 indexed citations
18.
Ibarrola, Jaime, Ernesto Martínez‐Martínez, Rafael Sádaba, et al.. (2017). Beneficial Effects of Galectin-3 Blockade in Vascular and Aortic Valve Alterations in an Experimental Pressure Overload Model. International Journal of Molecular Sciences. 18(8). 1664–1664. 21 indexed citations
19.
Martínez‐Martínez, Ernesto, Mathieu Buonafine, Inès Boukhalfa, et al.. (2017). Aldosterone Target NGAL (Neutrophil Gelatinase–Associated Lipocalin) Is Involved in Cardiac Remodeling After Myocardial Infarction Through NFκB Pathway. Hypertension. 70(6). 1148–1156. 68 indexed citations
20.
Martínez‐Martínez, Ernesto, Jaime Ibarrola, Laurent Calvier, et al.. (2016). Galectin-3 Blockade Reduces Renal Fibrosis in Two Normotensive Experimental Models of Renal Damage. PLoS ONE. 11(11). e0166272–e0166272. 50 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026